Clinical Trials


Clinical Trials are an essential component of cancer research and care. They are one of the main ways that discoveries made at the bench are translated and reach the general public. Clinical trials are large, systematic tests that identify if new treatments or treatment combinations actually work against cancer. Clinical trials are divided into different types, called phases. Phase I trials assess the general safety and tolerability of a new drug. Phase II trials test the efficacy of a new drug, while Phase III trials test the efficacy of a new drug in large groups of patients. Clinical trials are a great way for patients to get access to new, cutting-edge treatments. Patients and caregivers can look up clinical trials for their specific cancer types in their region using the US Government Clinical Trials Website. The clinically oriented LCRC partner institutions all have active cancer clinical trials. Tulane’s open clinical trials cover a number of different cancers including brain, breast, colorectal, leukemia, and prostate cancers. LSU Health is part of the Gulf South Clinical Trials Network. Ochsner also has active clinical trials. All of these LCRC partner institutions are committed to bringing the most cutting-edge cancer therapies to the New Orleans, Louisiana, and Gulf South region through participation in and administration of clinical trials.

Investigator Initiated Clinical Trials
Pharmaceutical Company Clinical Trials

Areas of focus